1.
SQUMJ-Sultan Qaboos University Medical Journal. 2013; 13 (2): 318-322
in English
| IMEMR
| ID: emr-126038
ABSTRACT
Pulmonary complications in leptospirosis, though common, are often unrecognized in a non-endemic area. We report here a patient with leptospirosis and severe pulmonary involvement who was treated with meropenem [1 g every 8 hours], moxifloxacin [400 mg once daily], and high doses of corticosteroids. Systemic steroids were continued for 3 months because of persistent pulmonary lesions